Sun, Jan 04, 26
Long-Term Safety of Anti-CGRP Monoclonal Antibodies
A comprehensive meta-analysis of over 4,300 patients reveals that erenumab, galcanezumab, fremanezumab, and eptinezumab maintain good tolerability beyond 12 months. Only 3% of patients stopped treatment due to adverse events,...
Read MoreThu, Jan 01, 26
Alternate Nostril Breathing Protocol for Migraine
Alternate nostril breathing is a simple yogic technique that's showing real promise for migraine prevention. Unlike acute treatments, this practice builds nervous system resilience over time - making attacks less...
Read MoreFri, Dec 26, 25
Why Migraine and Jaw Pain Go Together: New Research (2025) Explains the Link
A 2025 systematic review of over 10,000 patients confirms a strong bidirectional link between migraine and temporomandibular disorders. People with migraine are 6 times more likely to develop TMD, while...
Read More

